Loss of Smell and Taste Validated as COVID-19 Symptoms
April 13, 2020
Researchers at UC San Diego Health publish the first empirical findings that strongly associate sensory loss and COVID-19, the respiratory disease caused by the novel coronavirus.
Your search for “Covid-19” returned 609 results
UC San Diego Health Offers Virtual Appointments to Patients with COVID-19
May 4, 2020
UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.
Young, Healthy Woman Suffers Brain Inflammation after Mild COVID-19 Infection
August 9, 2021
UC San Diego Health physicians describe first known case of young, healthy adult experiencing central nervous system inflammation due to COVID-19, but without cognitive impairment.
Study: COVID-19 Infection Combined with Blood Clots Worsen Patient Outcomes
November 23, 2020
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with an increased tendency of the blood to clot, leading to a higher risk of death from COVID-19.
Disparities in United States COVID-19 Vaccine Distribution
July 28, 2022
Health care facilities in Black metropolitan counties, Hispanic rural counties and hardest-hit counties were less likely to administer COVID-19 vaccines during initial rollout, UC San Diego study finds.
Kids With MIS-C Mount Normal T Cell Response to COVID-19
October 7, 2021
UC San Diego study suggests multisystem inflammatory syndrome in children (MIS-C), a rare condition associated with COVID-19, is not caused by abnormal T cell response to COVID-19 virus as previously hypothesized.
Common Medication Used to Reduce Cholesterol Levels May Reduce COVID-19 Severity
July 15, 2021
Using anonymized medical records from a national registry, UC San Diego researchers confirm earlier findings that statins may substantially minimize adverse outcomes from SARS-CoV-2 infection.
Arthritis Drug Presents Promise as Treatment for COVID-19 Pneumonia
April 29, 2020
UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.
Introducing COVID19questions.org
September 17, 2020
A consortium of 12 health systems, led by UC San Diego Health, introduces COVID19questions.org, a site where clinicians, researchers, patients and the general public are invited to submit questions that could be answered by COVID-19 patient medical record data from 200+ hospitals.
Conrad Prebys Foundation Awards $350,000 Challenge Grant to Support UC San Diego’s COVID-19 Efforts
April 13, 2020
San Diego-based The Conrad Prebys Foundation today awarded a $350,000 challenge grant to support the University of California San Diego in its COVID-19 efforts. The purpose of the foundation’s match opportunity is to raise funds specifically for frontline health care in the region.
